Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study
Open Access
- 1 June 2006
- journal article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 82 (3) , 212-218
- https://doi.org/10.1136/sti.2005.017186
Abstract
Objective: To estimate the cumulative incidence of severe complications associated with genital chlamydia infection in the general female population. Methods: The Uppsala Women’s Cohort Study was a retrospective population based cohort study in Sweden, linking laboratory, hospital, and population registers. We estimated the cumulative incidence of hospital diagnosed pelvic inflammatory disease, ectopic pregnancy, and infertility, and used multivariable regression models to estimate hazard ratios according to screening status. Results: We analysed complete data from 43 715 women in Uppsala aged 15–24 years between January 1985 and December 1989. Follow up until the end of 1999 included 709 000 woman years and 3025 events. The cumulative incidence of pelvic inflammatory disease by age 35 years was 3.9% (95% CI 3.7% to 4.0%) overall: 5.6% (4.7% to 6.7%) in women who ever tested positive for chlamydia, 4.0% (3.7% to 4.4%) in those with negative tests, and 2.9% (2.7% to 3.2%) in those who were never screened. The corresponding figures were: for ectopic pregnancy, 2.3% (2.2% to 2.5%) overall, 2.7% (2.1% to 3.5%), 2.0% (1.8% to 2.3%), and 1.9% (1.7% to 2.1%); and for infertility, 4.1% (3.9% to 4.3%) overall, 6.7% (5.7% to 7.9%), 4.7% (4.4% to 5.1%), and 3.1% (2.8% to 3.3%). Low educational attainment was strongly associated with the development of all outcomes. Conclusions: The incidence of severe chlamydia associated complications estimated from ours, and other population based studies, was lower than expected. Studies that incorporate data about pelvic inflammatory disease diagnosed in primary care and behavioural risk factors would further improve our understanding of the natural history of chlamydia. Our results provide reassurance for patients, but mean that the benefits of chlamydia screening programmes might have been overestimated.Keywords
This publication has 35 references indexed in Scilit:
- Cost-benefit analysis of first-void urine chlamydia trachomatis screening programPublished by Wolters Kluwer Health ,2006
- Discordance between trends in chlamydia notifications and hospital admission rates for chlamydia related diseases in New South Wales, AustraliaSexually Transmitted Infections, 2005
- Ectopic Pregnancies and Reproductive Capacity After Chlamydia trachomatis Positive and Negative Test Results: A Historical Follow-Up StudySexually Transmitted Diseases, 2005
- The Natural Course ofChlamydia trachomatisInfection in Asymptomatic Colombian Women: A 5‐Year Follow‐Up StudyThe Journal of Infectious Diseases, 2005
- The correct approach to modelling and evaluating chlamydia screeningSexually Transmitted Infections, 2004
- Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analysesInternational Journal of Epidemiology, 2004
- Diagnosis of pelvic inflammatory disease: time for a rethinkSexually Transmitted Infections, 2003
- What should we do about screening for genital chlamydia?International Journal of Epidemiology, 2002
- Prevention of Pelvic Inflammatory Disease by Screening for Cervical Chlamydial InfectionNew England Journal of Medicine, 1996
- Effect of Treatment Regimens forNeisseria gonorrhoeaeon Simultaneous Infection withChlamydia trachomatisNew England Journal of Medicine, 1984